Alan Wake 2 crosses 3 million copies sold as Remedy eyes Control Resonant launch

Alan Wake 2 has hit 3 million copies sold, Remedy confirmed in its H1 2026 financial report covering January through June. The milestone was reached during Q2 2026, making it the latest in a slow but steady climb for the investigative horror shooter.

The sales journey has been a long one. At launch, Alan Wake 2 moved only 1 million copies despite being Remedy's fastest-selling game at the time — not enough to cover its development and marketing costs. By early 2024 it had recouped most of those costs, and by February 2025 it crossed 2 million copies and finally turned a profit. The Epic Games Store exclusivity on PC has been a recurring point of criticism, with many players and analysts arguing the absence from Steam has capped its ceiling. The game was funded by Epic, which locked it to that storefront.

The broader financial picture at Remedy is less rosy right now. Revenue, profit, and cashflow all declined in H1 2026 — but the studio says that's expected, given heavy spending on development and marketing for Control Resonant, its upcoming sequel to the 2019 supernatural action game Control. Interestingly, anticipation for Control Resonant has given the original Control a sales bump in Q2, beating its record for the same period last year. Remedy currently has three projects in various stages: Control Resonant is nearly done, the Max Payne 1 and 2 remakes are in full production, and a third unannounced project is in the "production readiness" stage. Remedy's new CEO, who stepped into the role in February 2026, has been candid about the studio's commercial underperformance, saying Alan Wake and Control "should have sold more" and that Remedy "hasn't achieved half of the potential" of its games.

Control Resonant launches September 24th on PC, PS5, and Xbox Series X/S — and it's shaping up to be the most important release in Remedy's recent history. Whether it can finally deliver the commercial breakthrough the studio has been chasing remains the big question heading into the back half of 2026.